WAYNE, Pa., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has been awarded a contract for the supply of Central Venous Access ...

Teleflex Incorporated has announced a contract with Vizient, Inc. for the supply of its Central Venous Access Catheters and Arterial Catheters, effective January 1, 2025. Vizient, the largest provider ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced that Teleflex and Arrow International LLC are recalling both the Arrow MAC Two-Lumen Central ...

Please provide your email address to receive an email when new articles are posted on . Using data from the US Renal Data System, researchers identified 74,194 Medicare-eligible patients who initiated ...

There are many indications for the use of CVP catheters in the ICU. The most common include: 1. Vascular access: Many patients in the ICU are edematous, and peripheral vascular access may be difficult ...

Investigation of the relationship between serum hepcidin and prohepcidin in anemia of cancer (AoC) patients with the anemia of inflammation (AI) No significant financial relationships to disclose.

Warren Buffett, the US financier, famously said, “cost is what you pay, value is what you get.” The clinical study by Weisen et al 1 associated with our editorial puts a spotlight on the highly ...

Patients with testicular cancer had fewer venous access-related complications and overall thrombotic events when first-line chemotherapy was delivered via peripheral intravenous access compared with ...

| Future Market Insights NEWARK, Del., April 13, 2026 /PRNewswire/ -- According to the latest market analysis by Future Market Insights, the global central venous catheter market is witnessing ...